Cholinergic-anticholinergic antagonism in parkinsonism.
D000328:Adult; D001479:Basal Ganglia / Q000187:drug effects* / Q000503:physiopathology*; D003472:Curare / Q000627:therapeutic use*; D004336:Drug Antagonism; D004558:Electric Stimulation; D005260:Female; D006236:Handwriting; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy*; D010830:Physostigmine / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D012601:Scopolamine / Q000627:therapeutic use*
D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D003472:Curare; D010830:Physostigmine; D012601:Scopolamine